
LineaRx to Collaborate with Italian Companies Takis and Evvivax on Cancer Vaccines
Published: Sep 20, 2018 By Mark TerryLineaRx, a subsidiary of Applied DNA Sciences, has entered into a Joint Development Agreement with Takis SRL and Evvivax SLR. They will focus on developing anti-cancer vaccines. Under the terms of the deal, LineaRx and Takis and Evvivax will work together to develop linear DNA expression vectors of two of Takis/Evvivax’s anti-cancer vaccine candidates. They will use […]